Elise Reuter
Senior Reporter | @EliseReuterElise has spent most of her career writing about healthcare and technology for business publications. She was a data fellow for USC Annenberg’s Center for Health Journalism in 2020, where she covered hospitals' use of unregulated risk-prediction models and unequal access to Covid-19 vaccines and testing. She recently moved back to her home state of Colorado, where she enjoys hiking, skiing, reading and trying out new recipes. She can also be reached on Signal at elisereuter.78.
727 articles by Elise Reuter
-
Dexcom execs say company has fixed G7 quality problems
Oct. 31, 2025 -
Philips receives FDA warning letter over quality issues
Oct. 30, 2025 -
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B
Oct. 29, 2025 -
J&J partners with Nvidia on AI for kidney stone procedures
Oct. 28, 2025 -
Olympus execs talk about import alert, GI robot and AI
Oct. 28, 2025 -
J&J awards first grants from AI surgery fund
Oct. 27, 2025 -
Medtech industry closely watching Section 232 investigation
Oct. 24, 2025 -
Hemorrhage can be a serious problem after pregnancy. Here’s how one medtech founder is tackling it
Oct. 23, 2025 -
Hologic to go private for up to $18.3B
Oct. 21, 2025 -
Biolinq’s Jared Tangney on making CGMs unintimidating
Oct. 20, 2025 -
Dexcom faces proposed class action suit over G7 CGM problems
Oct. 20, 2025 -
Ōura raises $900M to develop new health features
Oct. 17, 2025 -
What J&J’s ortho spinoff means for the industry
Oct. 16, 2025 -
Abbott CEO: ‘We’re right on time’ to the PFA party
Oct. 15, 2025 -
5 AI takeaways from AdvaMed’s conference
Oct. 14, 2025 -
FDA’s presence at AdvaMed conference shrinks amid shutdown
Oct. 9, 2025 -
AdvaMed CEO: ‘Just give us some certainty’
Oct. 8, 2025 -
How 4 medtech CEOs are using AI
Oct. 7, 2025 -
Hospital for Special Surgery’s Ashis Barad says AI must solve real problems
Oct. 3, 2025 -
Boston Scientific aims for market leadership in electrophysiology
Oct. 2, 2025 -
Boston Scientific unveils plans for new Watchman device
Oct. 1, 2025 -
Medtech firms splitting into ‘haves’ and ‘have-nots’: EY
Sept. 29, 2025 -
Biolinq gets FDA de novo nod for intradermal glucose sensor
Sept. 26, 2025 -
Section 232 probe reignites tariff uncertainty for medtech firms
Sept. 26, 2025 -
Que Dallara on Medtronic’s diabetes spinoff, pipeline and Abbott partnership
Sept. 25, 2025